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Tuberculosis is the number one infectious cause of death globally. Young children, generally those younger than 5 years, are at
the highest risk of progressing from tuberculosis infection to tuberculosis disease and of developing the most severe forms of
tuberculosis. Most current tuberculosis drug formulations have poor acceptability among children and require consistent adherence
for prolonged periods of time. These challenges complicate children’s adherence to treatment and caregivers’daily administration
of the drugs. Rapid developments in mobile technologies and apps present opportunities for using widely available technology
to support national tuberculosis programs and patient treatment adherence. Pilot studies have demonstrated that mobile apps are
a feasible and acceptable means of enhancing children’s treatment adherence for other chronic conditions. Despite this, no mobile
apps that aim to promote adherence to tuberculosis treatment have been developed for children. In this paper, we draw on our
experiences carrying out research in clinical pediatric tuberculosis studies in South Africa. We present hypothetical scenarios of
children’s adherence to tuberculosis medication to suggest priorities for behavioral and educational strategies that a mobile app
could incorporate to address some of the adherence support gaps faced by children diagnosed with tuberculosis. We argue that
a mobile app has the potential to lessen some of the negative experiences that children associate with taking tuberculosis treatment
and to facilitate a more positive treatment adherence experience for children and their caregivers.
(JMIR Mhealth Uhealth 2020;8(11):e19154) doi: 10.2196/19154
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Tuberculosis (TB) is the number one infectious cause of death
globally [1]. Implementation of effective TB control programs
continues to place enormous pressure on the health systems of
high TB-burden countries [1]. The World Health Organization’s
(WHO) Global TB Program identifies digital health technologies
as key to supporting its new End TB Strategy [2]. An essential
component of this strategy includes using mobile technologies
and apps in particular to improve adherence to TB treatment
[2]. Reviews show that the development and implementation
of mobile health technologies to support health outcomes are
overwhelmingly concentrated in high-income countries and
focused on diseases of concern in those settings [3-5]. The
development and implementation of mobile health technologies
in low- and middle-income countries (LMICs), where the burden
of communicable diseases, such as TB, is markedly high and
treatment is strenuous, has received comparatively less attention.
In the last decade, rapid developments in mobile technologies
and apps, extended mobile network coverage, and increasing
possibilities for integrating mobile health into existing eHealth
platforms present opportunities for using widely available
technology to support TB programs and adherence in
resource-constrained and high-burden areas [2].
In South Africa, TB is the leading cause of death, mainly due
to the overlapping HIV and TB epidemics [1,6]. South Africa
also has the world’s second highest estimated TB incidence
rate, at 520 per 100,000 people [1]. In endemic areas, such as
South Africa, young children (especially younger than 5 years)
are at the highest risk to progress from TB infection to TB
disease and to develop the most severe forms of TB, such as
TB meningitis [7,8]. In 2018, children accounted for 7% of
newly recorded TB cases in South Africa [1]. Despite their
heightened risk, children’s paucibacillary TB disease leads to
them having much better treatment outcomes than their adult
counterparts once treatment is started [7]. Children’s timely
diagnosis and rapid initiation onto TB treatment are critical, as
undiagnosed cases or undertreatment could have long-term
health consequences or lead to death.
Drug-susceptible (DS) and drug-resistant (DR) TB treatment
formulations have had very poor acceptability among children
[9]. The drugs are multiple, unpalatable, and often cause
significant side effects, such as nausea, liver toxicity, insomnia
[1,7], neurosensory alterations, neuromuscular weakness, and
psychological and behavioral disturbances such as anger,
aggression, withdrawal, hyperactivity, and depressive symptoms
[10,11]. TB treatment is also lengthy and requires consistent
adherence for at least six months for DS-TB and, in the case of
DR-TB, adherence to different drug regimens for a longer period
of time [1,8]. Child-friendly TB preventive therapy and
treatment formulations that simplify and improve TB treatment
for children are either only recently available or are still being
evaluated in clinical trials [8,9,12]. The challenges presented
above complicate children’s adherence to treatment and
caregivers’ daily administration of the drugs [8].
Various small-scale and pilot studies in high-income settings
have demonstrated that mobile apps are a feasible and acceptable
means of enhancing children’s and young people’s treatment
adherence for chronic conditions, such as sickle cell disease
(SCD), migraines, asthma, and HIV [13-18]. There is limited
high-quality evidence on the impact of mobile apps on health
outcomes when implemented at scale or on how different mobile
app components affect health and treatment outcomes [3-5].
Despite this, many of the small-scale studies published thus far
provide promising evidence supporting the potential of mobile
apps to positively impact adherence and treatment outcomes
among children and young people [3-5,13,15,16,19]. These
studies also serve as a foundation for further research and
implementation efforts in this field and demonstrate the potential
for developing and implementing mobile apps in LMICs that
support children’s and caregivers’ burdensome TB treatment
journeys. To date, no mobile apps that aim to improve the
experience of TB and TB treatment in high- or low-income
countries have been developed for children; mobile health
interventions for supporting TB programs have largely focused
on adult patients, using SMS-based text message platforms to
promote TB treatment adherence, clinic attendance, and
monitoring [20-22].
In this paper, we reflect on our joint experience conducting
research in ongoing pediatric TB studies at the Desmond Tutu
TB Centre, Stellenbosch University, South Africa, to highlight
the potential for developing mobile app–based technologies to
support TB treatment adherence in children. First, we provide
an overview of technologies that have been used to support
children’s and young people’s treatment and adherence
experiences in other disease contexts. Second, we present
hypothetical scenarios informed by our experiences to illustrate
the adherence support gaps for children with TB. Third, we
imagine how a mobile app could address some of the adherence
support gaps faced by children affected by TB.
Overview of Adherence Technologies for
Children
Table 1 provides examples of studies that use mobile technology
to improve children’s and young people’s treatment adherence,
including for  SCD,  as thma,  migraine ,
attention-deficit/hyperactivity disorder, and HIV. These pilot
studies provide preliminary evidence that shows the potential
of mobile apps to support adherence in children and young
people.
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Table 1. Examples of studies that used mobile technology to improve children’s and young people’s treatment adherence.
Intervention featuresStudy summaryStudy
- Self-recorded videos of taking the medication
- Monetary incentives with successful adherence (US
$30 gift card)
- Text message reminders
- Personalized feedback on adherence from research
staff
- Single-arm intervention study with pediatric patients ≤19 years (median
age 10 years)
- Condition: SCDa
- Country: United States
- Intervention: effect of mobile phone–based intervention on adherence
to SCD treatment
- Outcomes: increased adherence among participants engaged with the
intervention over a 6-month period compared with participants’ baseline
adherence
Creary et al (2019)
[13]
- Reminder notifications and phone calls
- Incorporation of the health belief model
- Medication adherence tracking
- AB design pilot study with patients aged 13 to 21 years
- Condition: migraine
- Country: United States
- Intervention: evaluation of the use of a mobile app to increase adherence
to migraine medication
- Outcomes: similarly high rates of adherence among participants using
the intervention and participants using smart pill bottles over an 8-week




- Education (short movie clips)
- Medication reminders
- Chat feature with pharmacists
- Chat feature with peers
- Randomized controlled trial with patients aged 12 to 18 years
- Condition: asthma
- Country: Netherlands
- Intervention: measuring the impact of a mobile app on participants’
adherence to asthma treatment
- Outcomes: increased 6-month adherence rates among participants who
used the app and measured low-adherence rates at baseline. Decreased
6-month adherence rates measured among participants in the control
group




- Education on ADHD and its treatment (video clips,
articles, and links to additional reading materials)
- Randomized controlled trial with children aged 6 to 16 years
- Condition: ADHDb
- Country: Israel
- Intervention: assessing the use of a mobile app to increase ADHD
medication adherence
- Outcomes: increased adherence rates among participants who were





- Rewards system (points earned through interaction
with app’s features)
- Education on SCD
- Quiz (focused on education about SCD)
- Symptom tracking
- Medication and appointment reminders
- Emergency information for health professionals un-
familiar with SCD
- Study conducted with 12- to 18-year-olds
- Condition: SCD
- Country: multiple, including Lebanon and Nigeria
- Intervention: development of an evidence-based mobile app supporting
SCD medication adherence
- Outcomes: evaluation of the app is underway
Curtis et al (2019)
[23]
- Medication tracking
- Reward system (points and monetary incentive earned
through interaction with the app’s features)
- Social networking (social wall discussion questions)
- Gamification through quests and story-based frame-
work
- Incorporation of social cognitive theory
- Study conducted with 19- to 24-year-olds
- Condition: HIV
- Country: United States
- Intervention: pilot of a mobile app supporting HIV medication adherence
- Outcomes: high acceptability and feasibility, as measured in participant
ratings after 28 days of app use. A clinical trial evaluating adherence
with the app is underway
Hightow-Weidman
et al (2018) [18]
aSCD: sickle cell disease.
bADHD: attention-deficit/hyperactivity disorder.
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However, few technologies and mobile apps target children’s
treatment adherence specifically; for TB, no such technologies
exist. Common app features shared across the studies included
in Table 1 incorporated behavioral and educational strategies
to improve adherence through features such as reminder
notifications, adherence logging, cash or other adherence
rewards, and educational features [13-15,17,18,23]. While
evidence of the impact of these app components on adherence
is limited to small sample sizes, the studies that have completed
evaluations show increased or high rates of adherence in their
study populations [13-16,19], and an even greater number of
apps have shown high acceptability and feasibility among users
from various age categories [13-18]. For example, one of the
pilot studies, MyMate&Me, is a mobile app aiming to support
SCD medication adherence among children and adolescents
aged 12 to 18 years [23]. With MyMate&Me, users earn points
by participating in app features, including (1) “Tip of the Day,”
where users learn important information about coping with
SCD, (2) “Daily Quiz,” where users learn about SCD by
answering quiz questions and earning points for correct answers,
(3) “Mood Tracker,” where users earn points by logging their
daily mood, and (4) “Medication and Appointment Reminders,”
where users are reminded to take their medication, attend
appointments, and earn points for confirming their adherence
and attendance. MyMate&Me also features an avatar to
accompany the user throughout the app. The user can spend
their earned points on clothes and accessories for their avatar,
thereby providing incentive for using the app’s various
functionalities and managing their condition. Another study,
also on SCD, incorporated video directly observed therapy for
adherence monitoring, daily reminders via SMS text messages,
email, or telephone if adherence was not observed, and a US
$30 gift card incentive if users maintained at least 90%
adherence over 30 days [13].
The behavioral strategies used in these mobile apps aimed to
facilitate a favorable adherence environment and thus change
patient behavior, while the educational strategies aimed to
provide patients with information so that they could make
informed choices about adhering to treatment [24]. These
strategies are informed by underlying theories of human
behavior, such as the health belief model [25], the theory of
reasoned action or planned behavior [26], and operant
conditioning [27]. The basic logic of these theories is that people
are more likely to repeat behaviors (in this instance adherence)
that (1) are associated with reward, not punishment, (2) conform
to their perceptions of descriptive and injunctive norms, and
(3) are within their perceived self-control. Robust evidence
supporting the use of mobile apps and mobile app features that
use behavioral strategies is limited [3-5]; however, their
foundational principles have been evaluated extensively in
relation to a large variety of health behaviors in many settings
across the world [27,28] and have been shown to be supportive
of adherence [24]. In 2014, the WHO advocated for such
behavioral and educational strategies to be incorporated into
apps to improve TB treatment adherence [7].
What Are the Current Adherence Support
Gaps for Children With Tuberculosis?
Many mobile apps that support children’s and young people’s
adherence to treatment for other conditions serve as treatment
reminders or sources of information for patients
[13-15,17,18,23]. Drug palatability, tolerability, and
acceptability, which pose serious threats to adherence, are
typically not considered for intervention with mobile apps. In
Textbox 1, we draw on our experiences carrying out research
in pediatric TB studies at the Desmond Tutu TB Centre to
consider children’s and caregivers’ experiences with TB
treatment that illustrate specific adherence support gaps and
needs. The scenarios reflect typical interactions with patients
and caregivers that are observed daily in TB service delivery
contexts. They show that caregivers and children are generally
motivated and knowledgeable about TB treatment but that the
unpalatability, number, and side effects of the drugs affect their
acceptability and provide serious challenges for caregivers and
children at each ingestion event. We argue that an important
user need is making the drug ingestion and administration
experience more acceptable. For children especially, the current
TB treatment experience is negative, and they are “punished”
by the negative associations and poor palatability at each
ingestion event. Alongside advocating for improved,
child-friendly, palatable formulations, a mobile app that can
mitigate the punishment associated with treatment and provide
tangible rewards closely associated with each adherence event
is a priority and could serve as a supporting component for
improving the TB treatment experience for children and their
caregivers. The app could also, for example, provide users with
tutorial videos for pairing TB treatment with foods to improve
palatability without compromising dosing accuracy [29].
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Textbox 1. Scenarios reflecting specific adherence support gaps and needs.
Scenario 1
Bernice is the mother of 2-year-old Lindiwe and takes her role in administering Lindiwe’s tuberculosis (TB) treatment very seriously. Every day when
it is time to administer Lindiwe’s treatment, Bernice endures frightful temper tantrums due to the drugs’ poor taste. Bernice finds that the daily
frustration and struggle of ensuring Lindiwe ingests her medication is mentally wearing, and she has had to be increasingly resourceful to plan for
and strategize ways of getting Lindiwe to take her treatment, including begging, bribing, forcing, cheering, and more. In this scenario, the adherence
gap is Bernice’s struggle to be resourceful and find new ways to administer the TB medication due to the medication’s poor acceptability.
Scenario 2
Angela’s 7-year-old son, Henry, often experiences significant nausea when he takes his TB treatment. On occasion, the treatment causes him to vomit.
The process of giving Henry his TB medication has become a daily battle for Angela and often involves her forcing the medication into him. This
arrangement is beginning to negatively affect their relationship. The adherence support gap in this scenario is the negative effect of the TB medication’s
poor palatability and acceptability on Angela’s relationship with Henry.
Scenario 3
Despite being only 5 years old, Alice understands that taking TB medication is an important daily task. When it is time for her mother, Gill, to take
her own TB medication, Alice reminds her by saying “pills, Mommy, pills.” However, understanding the importance of TB treatment does not help
Alice’s adherence; she puts up a great fight each time she has to take her own treatment. In this scenario, the adherence support gap is that Alice’s
understanding of the importance of TB treatment is not enough to overcome the poor acceptability of the treatment.
How Could Technology Address These
Gaps?
In order to address the current treatment support gaps for
children with TB in South Africa, we conceptualize a mobile
app that incorporates behavioral and educational strategies to
include an avatar, a rewards scheme, reminder notifications,
adherence tracking, social support for children and caregivers,
and information on TB, TB treatment, and TB treatment
adherence, with the overall aim of reducing the negative
emotions associated with TB treatment for children. The
connections between treatment support gaps, strategies, and
app features are presented in Table 2.
Table 2. Summary of adherence gaps and their hypothetical corresponding mobile app features.
App features: behavioralApp features: educationalAdherence gap
- An avatar to reduce children’s negative emotions toward treatment and
demonstrate the consequences of adherence
- Rewards scheme to reduce children’s negative emotions toward treatment
- Social support for children from peers
Information about the rewards of
adherence and the consequences of
nonadherence
Poor acceptability and palatability
of TBa treatment for children
- Reminder notifications and medication tracking associated with behavior-
changing rewards
- Social support and advice from other caregivers
Access to advice and information
from health professionals
Caregivers’ challenges finding
strategies to administer TB treat-
ment
- Rewards scheme to reduce children’s negative emotions toward treatment
- Social support and advice for caregivers from other caregivers
- Social support for children from peers
- An avatar to reduce children’s negative emotions toward treatment
Access to advice and information
from health professionals
Negative effect of the strain of TB
treatment on the child-caregiver re-
lationship
- An avatar to reduce children’s negative emotions toward treatment and
demonstrate the rewards of adherence
- Rewards scheme to reduce children’s negative emotions toward treatment
- Social support for children from peers
Information about the rewards of
adherence and the consequences of
nonadherence
Poor acceptability of TB treatment
outweighing the importance of TB
treatment for children
aTB: tuberculosis.
We propose that the child creates an avatar to represent
themselves within the app. The avatar is given opportunities to
thrive (eg, growing noticeably stronger or getting better outfits
or gear) by completing tasks so that patients are rewarded for
active engagement in their care rather than punished for
noncompliance, as is the current norm. The avatar serves as an
externalization of the child’s experiences with treatment. If the
child cares for their avatar, then the avatar will grow increasingly
sophisticated; achieving this is a reward in itself for the child.
For example, in such an app, users may complete missions in
order to gain diamonds—the currency of the app—that can be
used to purchase clothes and accessories for the avatar in the
app’s store. Completing missions also leads to levelling up each
time the user acquires the required number of diamonds. Each
mission might include linked goals, such as following the
treatment plan for 3 consecutive days, reading about TB, and
joining an online forum discussion. As a user completes
missions, earns diamonds, and levels up, their avatar becomes
stronger. “Adherence streaks” unlock bonus rewards and items
in the app’s store: the longer the adherence streak, the greater
the reward. Rewards can be scaled over time so that the user
has increasingly higher targets to achieve. As a further incentive,
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such an app could partner with businesses to offer small tangible
rewards, such as mobile data or discounts at selected stores.
The app, by encouraging the child’s active participation in their
treatment adherence, assigns positive consequences to taking
their medication (eg, diamonds, a visibly stronger avatar, and
more accessories) and permits the child to gain control and
autonomy over the treatment experience. It also ties rewards to
adherence despite the unpalatability of the drugs and negative
side effects. Interventions that use rewards to promote
medication adherence have been shown to be significantly more
efficacious than interventions that do not use rewards [30]. The
aforementioned features of the app’s design also have the
potential to lower the risk of user fatigue. In an app supporting
TB treatment adherence, the risk of user fatigue is mitigated,
as the need for using the app naturally ends upon treatment
completion, at which point the user’s avatar could enter a hall
of fame.
Building on a fundamental link between the avatar’s wellness
and the child’s adherence behaviors, a mobile app could then
incorporate a range of other features to support children and
caregivers in adhering to treatment. For instance, the app could
be an important source of information on TB. It could include
medication reminders, alerts for upcoming clinic visits, and
details of what to expect at the visit. Daily adherence logging
would allow users to track their adherence over time, view
weekly and monthly adherence, and progress toward completing
their treatment course. An in-app community space would allow
caregivers to interact with other caregivers. Caregiver
participation in the community would earn their child diamonds,
making knowledge seeking collaborative and providing
caregivers with a new adherence resource and a free, positive
reward to help mitigate the negative effects of forced
administration on the child-caregiver relationship. In the online
forum, caregivers and older children with appropriate
supervision would be able to ask each other about their
experiences with TB and treatment, creating an additional social
support system.
Studies of TB knowledge in South Africa have suggested
relatively good levels of understanding of prevention and cure
among the population, but knowledge of TB cause and
symptoms was suggested to be low [31,32]. A frequently asked
questions (FAQs) section, designed by children and adolescents
who have experienced TB disease and medical professionals
who work with TB disease, could address knowledge gaps by
including answers to common questions, such as “How can I
protect my family and friends from getting TB?” “What kind
of bodily changes can I expect while taking treatment?” “Can
I go to school if I have TB?” and “What is the relationship
between TB and HIV?” In the app’s community space, users
can also play games (racing, sports, treasure hunts, etc), either
with each other or solo, to earn additional diamonds. The
stronger their avatar (eg, the better their adherence), the more
competitively they will perform in the games. The effectiveness
of such games for increasing medication adherence among
children has been shown [33,34]. For example, in a randomized
controlled trial, a video game intervention was found to improve
medication adherence and behavioral outcomes for young people
aged 13 to 29 years with acute leukemia, lymphoma, or
soft-tissue sarcoma in the United States, Canada, and Australia
[33].
In a high TB-burden, resource-limited setting like South Africa,
such a mobile app that aims to facilitate children’s adherence
to TB treatment could improve the patient experience and also
potentially buffer some of the shortcomings of the care provided
in an overburdened health service. In particular, a mobile app
could offer avenues of support to caregivers and children that
are not immediately available in service encounters. It could
also be a source of information on a range of topics related to
the disease and its treatment, as in the FAQ section proposed.
The immediate availability of such support and information has
the potential to be empowering for patients.
Considerations for Implementation
There are a number of practical considerations for developing
and using mobile apps to support children’s adherence in
culturally diverse, developing health settings, such as South
Africa. First, most households in low socioeconomic settings
have limited access to phones and tablets that could support
apps. Programs may consider providing patients with
smartphones during treatment, with the possibility of taking
ownership when treatment has been completed successfully.
The resources required to deliver such an app (if effective in
improving adherence) are limited to the supply of a suitable
mobile device (about US $40 per user) and some training on
how to use the app. Studies suggest that the cost of providing
smartphones to patients and supporting app-based adherence is
more cost-effective for patients and health services than current
adherence support models, which are often highly
labor-intensive, requiring many hours of health workers’ time
[35,36]. The app would also require some tailoring to the age
of the child to provide age-appropriate services and support,
including features for older children and adolescents who may
experience greater treatment autonomy. During the app’s initial
setup, a prompt to input age can align the app’s functionality
with the age of the child. To be acceptable amongst diverse
users, the app must be attuned to the local context in which it
will be implemented. As such, the app’s avatar must offer an
array of characteristics that users can select to reflect their social,
cultural, racial, and gender identities and their personalities.
These could be informed by participatory research through focus
group discussions and key informant interviews with end users,
community advisory boards, patient advocacy groups, and other
stakeholders. The project team can then partner with an expert
in app design, development, and programming. Last, the app
should take into account the diversity of languages spoken in
the local context and thereby allow children and caregivers to
use the app in the language most suitable to them.
Given the paucity of robust evidence for using mobile apps to
support adherence in children and adults, we suggest that future
evaluations of mobile adherence apps to support children’s
adherence to TB treatment should include implementation
science evaluations and randomized controlled trials. Further,
such evaluations should measure both biomedical (eg, treatment
success) and patient experience (eg, preferences and user
satisfaction) outcomes.
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Digital health technology is a burgeoning resource for
supporting health systems and patients in the prevention,
treatment, and care of a wide array of diseases. While such
technologies hold promise for supporting the adherence of
children diagnosed with TB disease in LMICs, where the burden
is highest, no such technologies have been developed to date.
In this paper, we presented some hypothetical scenarios of the
daily struggles of caregivers and children who are tasked with
adhering to TB treatment for prolonged periods of time. While
we do not suggest that a mobile app will resolve all problems
related to children’s adherence to treatment, such a technology
could compensate for and lessen some of the negative
experiences children associate with taking TB treatment and
perhaps even act as a buffer for health system shortcomings. It
remains the task of the research community to develop such
technologies and bring them to scale in the health systems in
which they will have the greatest impact.
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